Imaging Neural Correlates of Ketamine Using PET/MR
Status:
Not yet recruiting
Trial end date:
2023-09-30
Target enrollment:
Participant gender:
Summary
The purpose of this randomized, placebo-controlled study is to investigate pharmacodynamic
differences between racemic ketamine and esketamine using functional fluorodeoxyglucose
([18F]FDG) positron emission tomography/magnetic resonance imaging (PET/MR)